Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in Nigeria

PLoS ONE - Tập 11 Số 2 - Trang e0147182
Walter Royal1, Mariana Cherner2, Tricia H. Burdo3, Anya Umlauf2, Scott Letendre3, Jibreel Jumare4,5, Alash’le Abimiku4,5, Peter Alabi6, Nura H. Alkali7, Sunday Bwala8, Kanayo Okwuasaba4,5, Lindsay M. Eyzaguirre5, Christopher Akolo4,5, Ming‐Lei Guo1, Kenneth C. Williams3, William A. Blattner4
1Department of Neurology, University of Maryland, School of Medicine, Baltimore, Maryland, United States of America
2HIV Neurobehavioral Research Center, University of California San Diego, School of Medicine, San Diego, California, United States of America
3Department of Biology, Boston College, Chestnut Hill, Massachusetts, United States of America
4Institute for Human Virology, University of Maryland, School of Medicine, Baltimore, Maryland, United States of America
5Institute for Human Virology-Nigeria, Abuja, Nigeria
6University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria
7Abubakar Tafawa Balewa University Teaching Hospital, Bauchi, Nigeria
8National Hospital, Abuja, Nigeria

Tóm tắt

Từ khóa


Tài liệu tham khảo

RK Heaton, 2011, HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors, J Neurovirol, 17, 3, 10.1007/s13365-010-0006-1

RK Heaton, 2010, HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study, Neurology, 75, 2087, 10.1212/WNL.0b013e318200d727

W Royal III, 2012, Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria, J Neurovirol, 18, 191, 10.1007/s13365-012-0097-y

F Odiase, 2006, Effect of progression of disease on cognitive performance in HIV/AIDS, J Natl Med Assoc, 98, 1260

FK Salawu, 2008, Cognitive function in HIV-seropositive Nigerians without AIDS, J Neurol Sci, 267, 142, 10.1016/j.jns.2007.10.013

C Akolo, 2014, Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria, J Neurovirol, 20, 380, 10.1007/s13365-014-0254-6

KA Hestad, 2012, Sex differences in neuropsychological performance as an effect of human immunodeficiency virus infection: a pilot study in Zambia, Africa, J Nerv Ment Dis, 200, 336, 10.1097/NMD.0b013e31824cc225

ML Denton, 2013, Hyperthermia sensitizes pigmented cells to laser damage without changing threshold damage temperature, J Biomed Opt, 18, 110501, 10.1117/1.JBO.18.11.110501

OL Lopez, 1999, Neurological characteristics of HIV-infected men and women seeking primary medical care, Eur J Neurol, 6, 205, 10.1111/j.1468-1331.1999.tb00014.x

RA Stern, 1998, Neurobehavioral functioning in asymptomatic HIV-1 infected women, J Int Neuropsychol Soc, 4, 172, 10.1017/S1355617798001726

RS Durvasula, 2001, Predictors of neuropsychological performance in HIV positive women, J Clin Exp Neuropsychol, 23, 149, 10.1076/jcen.23.2.149.1211

TH Burdo, 2013, Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection, AIDS, 27, 1387, 10.1097/QAD.0b013e32836010bd

TH Burdo, 2011, Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients, J Infect Dis, 204, 1227, 10.1093/infdis/jir520

LA Ryan, 2001, Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection, J Infect Dis, 184, 699, 10.1086/323036

T Fischer-Smith, 2001, CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection, J Neurovirol, 7, 528, 10.1080/135502801753248114

E Lien, 1998, Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events, Blood, 92, 2084, 10.1182/blood.V92.6.2084

L Pulliam, 1997, Unique monocyte subset in patients with AIDS dementia, Lancet, 349, 692, 10.1016/S0140-6736(96)10178-1

WHO (2007) WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children.

CL Carey, 2004, Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection, J Clin Exp Neuropsychol, 26, 307, 10.1080/13803390490510031

AT Beck, 1996, Beck Depression Inventory

TH Burdo, 2011, Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy, J Infect Dis, 204, 154, 10.1093/infdis/jir214

P Ancuta, 2008, Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients, PLoS One, 3, e2516, 10.1371/journal.pone.0002516

JL Lyons, 2011, Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection, J Acquir Immune Defic Syndr, 57, 371, 10.1097/QAI.0b013e3182237e54

K Marder, 1995, Risk of human immunodeficiency virus type 1-related neurologic disease in a cohort of intravenous drug users, Arch Neurol, 52, 1174, 10.1001/archneur.1995.00540360052016

H Farzadegan, 1998, Sex differences in HIV-1 viral load and progression to AIDS, Lancet, 352, 1510, 10.1016/S0140-6736(98)02372-1

KR Robertson, 2004, No gender differences in the progression of nervous system disease in HIV infection, J Acquir Immune Defic Syndr, 36, 817, 10.1097/00126334-200407010-00008

I Jarrin, 2008, Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women, Am J Epidemiol, 168, 532, 10.1093/aje/kwn179

GM Goodwin, 1996, The Edinburgh cohort of HIV-positive injecting drug users at 10 years after infection: a case-control study of the evolution of dementia, AIDS, 10, 431, 10.1097/00002030-199604000-00012

M Cherner, 2004, Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings, AIDS, 18, S27, 10.1097/00002030-200401001-00005

KB Brauer, 2000, Handbood of Cross-Cultural Neuropsychology, 73

EN Fish, 2008, The X-files in immunity: sex-based differences predispose immune responses, Nat Rev Immunol, 8, 737, 10.1038/nri2394

MS Meltzer, 1990, Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection, Annu Rev Immunol, 8, 169, 10.1146/annurev.iy.08.040190.001125

E Anderson, 2002, HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes, J Acquir Immune Defic Syndr, 31, S43, 10.1097/00126334-200210012-00004

V Naranbhai, 2014, Ratio of monocytes to lymphocytes in peripheral blood identifies adults at risk of incident tuberculosis among HIV-infected adults initiating antiretroviral therapy, J Infect Dis, 209, 500, 10.1093/infdis/jit494

ZS Huang, 1996, In hypercholesterolemia, lower peripheral monocyte count is unique among the major predictors of atherosclerosis, Arterioscler Thromb Vasc Biol, 16, 256, 10.1161/01.ATV.16.2.256

S Bergmann, 1998, Even moderate cigarette smoking influences the pattern of circulating monocytes and the concentration of sICAM-1, Respir Physiol, 114, 269, 10.1016/S0034-5687(98)00098-X

KL Timmerman, 2008, Exercise training-induced lowering of inflammatory (CD14+CD16+) monocytes: a role in the anti-inflammatory influence of exercise?, Journal of Leukocyte Biology, 84, 1271, 10.1189/jlb.0408244

JM Brenchley, 2006, Microbial translocation is a cause of systemic immune activation in chronic HIV infection, Nat Med, 12, 1365, 10.1038/nm1511

M Kristiansen, 2001, Identification of the haemoglobin scavenger receptor, Nature, 409, 198, 10.1038/35051594

E Backe, 1991, Ber-MAC3: new monoclonal antibody that defines human monocyte/macrophage differentiation antigen, J Clin Pathol, 44, 936, 10.1136/jcp.44.11.936

LK Weaver, 2006, Pivotal advance: activation of cell surface Toll-like receptors causes shedding of the hemoglobin scavenger receptor CD163, J Leukoc Biol, 80, 26, 10.1189/jlb.1205756

KA Hintz, 2002, Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163, J Leukoc Biol, 72, 711, 10.1189/jlb.72.4.711

HJ Moller, 2002, Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasma, Blood, 99, 378, 10.1182/blood.V99.1.378

A Etzerodt, 2010, Tumor necrosis factor alpha-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163, J Leukoc Biol, 88, 1201, 10.1189/jlb.0410235

P Hogger, 2001, Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation, Biochem Biophys Res Commun, 288, 841, 10.1006/bbrc.2001.5845

WK Kim, 2006, CD163 identifies perivascular macrophages in normal and viral encephalitic brains and potential precursors to perivascular macrophages in blood, Am J Pathol, 168, 822, 10.2353/ajpath.2006.050215

KV Fitch, 2013, Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women, J Infect Dis, 208, 1737, 10.1093/infdis/jit508

A Jaworowski, 2007, CD16+ monocyte subset preferentially harbors HIV-1 and is expanded in pregnant Malawian women with Plasmodium falciparum malaria and HIV-1 infection, J Infect Dis, 196, 38, 10.1086/518443

NC Sacktor, 1996, Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death, J Neurovirol, 2, 404, 10.3109/13550289609146906

NG Sandler, 2011, Plasma levels of soluble CD14 independently predict mortality in HIV infection, J Infect Dis, 203, 780, 10.1093/infdis/jiq118

RJ Ellis, 1997, Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group, Arch Neurol, 54, 416, 10.1001/archneur.1997.00550160054016